Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential

Detalhes bibliográficos
Autor(a) principal: Souza, Renato Teixeira
Data de Publicação: 2019
Outros Autores: Mayrink, Jussara, Leite, Débora Farias, Costa, Maria Laura, Caldero, Iracema Mattos, Rocha Filho, Edilberto Alves, Vettorazzi, Janete, Feitosa, Francisco Edson, Cecatti, José Guilherme
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/157901
Resumo: The prediction or early diagnosis of maternal complications is challenging mostly because the main conditions, such as preeclampsia, preterm birth, fetal growth restriction, and gestational diabetes mellitus, are complex syndromes with multiple underlying mechanisms related to their occurrence. Limited advances in maternal and perinatal health in recent decades with respect to preventing these disorders have led to new approaches, and “omics” sciences have emerged as a potential field to be explored. Metabolomics is the study of a set of metabolites in a given sample and can represent the metabolic functioning of a cell, tissue or organism. Metabolomics has some advantages over genomics, transcriptomics, and proteomics, as metabolites are the final result of the interactions of genes, RNAs and proteins. Considering the recent “boom” in metabolomic studies and their importance in the research agenda, we here review the topic, explaining the rationale and theory of the metabolomic approach in different areas of maternal and perinatal health research for clinical practitioners. We also demonstrate the main exploratory studies of these maternal complications, commenting on their promising findings. The potential translational application of metabolomic studies, especially for the identification of predictive biomarkers, is supported by the current findings, although they require external validation in larger datasets and with alternative methodologies.
id USP-19_e22e10a35ed47001cda583e27a879f94
oai_identifier_str oai:revistas.usp.br:article/157901
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potentialMaternal Health (MeSH)Metabolomics (MeSH);Translational Medical Research (MeSH)PredictionThe prediction or early diagnosis of maternal complications is challenging mostly because the main conditions, such as preeclampsia, preterm birth, fetal growth restriction, and gestational diabetes mellitus, are complex syndromes with multiple underlying mechanisms related to their occurrence. Limited advances in maternal and perinatal health in recent decades with respect to preventing these disorders have led to new approaches, and “omics” sciences have emerged as a potential field to be explored. Metabolomics is the study of a set of metabolites in a given sample and can represent the metabolic functioning of a cell, tissue or organism. Metabolomics has some advantages over genomics, transcriptomics, and proteomics, as metabolites are the final result of the interactions of genes, RNAs and proteins. Considering the recent “boom” in metabolomic studies and their importance in the research agenda, we here review the topic, explaining the rationale and theory of the metabolomic approach in different areas of maternal and perinatal health research for clinical practitioners. We also demonstrate the main exploratory studies of these maternal complications, commenting on their promising findings. The potential translational application of metabolomic studies, especially for the identification of predictive biomarkers, is supported by the current findings, although they require external validation in larger datasets and with alternative methodologies.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2019-05-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://www.revistas.usp.br/clinics/article/view/15790110.6061/clinics/2019/e894Clinics; Vol. 74 (2019); e894Clinics; v. 74 (2019); e894Clinics; Vol. 74 (2019); e8941980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/157901/153190https://www.revistas.usp.br/clinics/article/view/157901/153591Copyright (c) 2019 Clinicsinfo:eu-repo/semantics/openAccessSouza, Renato TeixeiraMayrink, JussaraLeite, Débora FariasCosta, Maria LauraCaldero, Iracema MattosRocha Filho, Edilberto AlvesVettorazzi, JaneteFeitosa, Francisco EdsonCecatti, José Guilherme2019-05-24T13:16:00Zoai:revistas.usp.br:article/157901Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2019-05-24T13:16Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential
title Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential
spellingShingle Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential
Souza, Renato Teixeira
Maternal Health (MeSH)
Metabolomics (MeSH);
Translational Medical Research (MeSH)
Prediction
title_short Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential
title_full Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential
title_fullStr Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential
title_full_unstemmed Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential
title_sort Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential
author Souza, Renato Teixeira
author_facet Souza, Renato Teixeira
Mayrink, Jussara
Leite, Débora Farias
Costa, Maria Laura
Caldero, Iracema Mattos
Rocha Filho, Edilberto Alves
Vettorazzi, Janete
Feitosa, Francisco Edson
Cecatti, José Guilherme
author_role author
author2 Mayrink, Jussara
Leite, Débora Farias
Costa, Maria Laura
Caldero, Iracema Mattos
Rocha Filho, Edilberto Alves
Vettorazzi, Janete
Feitosa, Francisco Edson
Cecatti, José Guilherme
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Souza, Renato Teixeira
Mayrink, Jussara
Leite, Débora Farias
Costa, Maria Laura
Caldero, Iracema Mattos
Rocha Filho, Edilberto Alves
Vettorazzi, Janete
Feitosa, Francisco Edson
Cecatti, José Guilherme
dc.subject.por.fl_str_mv Maternal Health (MeSH)
Metabolomics (MeSH);
Translational Medical Research (MeSH)
Prediction
topic Maternal Health (MeSH)
Metabolomics (MeSH);
Translational Medical Research (MeSH)
Prediction
description The prediction or early diagnosis of maternal complications is challenging mostly because the main conditions, such as preeclampsia, preterm birth, fetal growth restriction, and gestational diabetes mellitus, are complex syndromes with multiple underlying mechanisms related to their occurrence. Limited advances in maternal and perinatal health in recent decades with respect to preventing these disorders have led to new approaches, and “omics” sciences have emerged as a potential field to be explored. Metabolomics is the study of a set of metabolites in a given sample and can represent the metabolic functioning of a cell, tissue or organism. Metabolomics has some advantages over genomics, transcriptomics, and proteomics, as metabolites are the final result of the interactions of genes, RNAs and proteins. Considering the recent “boom” in metabolomic studies and their importance in the research agenda, we here review the topic, explaining the rationale and theory of the metabolomic approach in different areas of maternal and perinatal health research for clinical practitioners. We also demonstrate the main exploratory studies of these maternal complications, commenting on their promising findings. The potential translational application of metabolomic studies, especially for the identification of predictive biomarkers, is supported by the current findings, although they require external validation in larger datasets and with alternative methodologies.
publishDate 2019
dc.date.none.fl_str_mv 2019-05-10
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/157901
10.6061/clinics/2019/e894
url https://www.revistas.usp.br/clinics/article/view/157901
identifier_str_mv 10.6061/clinics/2019/e894
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/157901/153190
https://www.revistas.usp.br/clinics/article/view/157901/153591
dc.rights.driver.fl_str_mv Copyright (c) 2019 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/xml
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 74 (2019); e894
Clinics; v. 74 (2019); e894
Clinics; Vol. 74 (2019); e894
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222764112543744